Vycor Medical, Inc.
VYCO
$0.07
$0.00-0.29%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 152.07% | -835.82% | 108.19% | 339.00% | -26.14% |
| Total Depreciation and Amortization | -2.48% | -4.73% | 1.27% | -4.46% | 3.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -48.37% | -98.37% | 219.15% | -- | 152.05% |
| Change in Net Operating Assets | 337.72% | 227.99% | -316.83% | -113.45% | -340.00% |
| Cash from Operations | 469.52% | 202.35% | -789.52% | -45.81% | -1,515.79% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -900.00% | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -3.28% | -- | -- |
| Total Debt Repaid | 15.82% | -7.19% | 21.35% | 50.94% | -10.63% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.82% | -7.19% | 12.46% | 50.94% | -10.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 294.39% | 143.85% | -192.69% | -48.67% | -232.84% |